The Role of Mental Health Providers in  Dual Diagnosis Substance Abuse Treatment by Gunawardena, Sanuri
Wright State University 
CORE Scholar 
Scholarship in Medicine - All Papers Scholarship in Medicine 
2020 
The Role of Mental Health Providers in Dual Diagnosis Substance 
Abuse Treatment 
Sanuri Gunawardena 
Follow this and additional works at: https://corescholar.libraries.wright.edu/scholarship_medicine_all 
 Part of the Chemicals and Drugs Commons 
The Role of Mental Health Providers in  
Dual Diagnosis Substance Abuse Treatment 
Sanuri Gunawardena 
Dr. Amber Todd, Office of Medical Education 
Population Health and Public Health  
Scholarship in Medicine  
☒By checking this box, I indicate that my mentor has read and reviewed my draft 
proposal prior to submission (I am in the April super short course) 
Abstract 
Objective: This research study aims to determine the impact of mental health provider ratio on 
drug overdose mortality. It also investigates how mental health provider ratio and the frequency 
of mental distress correlate. Additionally, the study examines how mental health provider ratios 
have changed in Ohio over time and how the Ohio drug overdose mortality rates compare to the 
rates in Michigan, another Midwestern state. Methods: Pearson/Spearman correlation tests were 
done to show how mental health provider ratio influences drug overdose mortality rate and how 
mental health provider ratio influences the frequency of mental distress. A paired samples t-test 
was done to show changes in mental health provider ratio in Ohio over time, while an unpaired 
samples t-test was done to compare drug overdose mortality in Ohio to Michigan. Results: A 
discussion of the results of this study will be available by May 2020.  
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Introduction/Literature Review  
More than approximately 750,000 Americans have died due to drug overdoses from the years 
1999 to 2018.1 However, overall overdose death rates in the United States decreased by 4.1% 
from 2017 to 2018.1 Despite progress in combating overdose deaths, death rates due to synthetic 
opioids, besides methadone, increased by 10% from 2017 to 2018.1 Specifically in Ohio in 2018, 
a total of 3,764 Ohio residents died from unintentional drug overdoses.2 Studies indicate that 
individuals with the most severe psychiatric disorders have the highest rates of co-occurring 
substance use disorders. The general population is averaging 17% with substance use disorder, 
while the numbers are 47% for those with schizophrenia, 56% for those with bipolar disorder, 
and 30% for people with another mood or anxiety disorder.3 The vast interconnections between 
mental illness and substance use disorders have been documented for over two decades.3–5  
Despite awareness of dual diagnoses, treatment of clients with co-occurring disorders has 
proven to be a barrier, as services are rarely tailored to address the elements of co-occurrence. 
One study found that forty-seven percent of individuals with opioid use disorder and co-
occurring mental illness did not receive behavioral health treatment.5 It was only in the early 
2000s that the U.S. Department of Health and Human Services released clinical guidelines 
combining mental health and substance abuse interventions. Yet, these new guidelines failed to 
include specific instructions for clinical subgroups.3 While the natural course of mental illness 
and substance use disorders trends toward recovery with appropriate interventions, for 
individuals with co-occurring disorders, there has been sparse long-term evidence through three-
year follow-ups indicating steady improvements.5  
Much focus has been placed on identifying methods to improve treatment interventions for 
individuals with co-occurring mental health and substance abuse disorders.6 Research shows that 
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recovery follows many pathways, and treatment interventions need to offer education and 
intervention choices and have a basis in shared decision-making.5 Such individualization of 
treatment programs would allow each patient to pursue a path that he or she truly believes in and 
will be likely to maintain. Similarly, peer-oriented groups have been shown to be the core of dual 
diagnosis treatment plans, with steady attendance for several months being crucial.7 These peer-
oriented sessions, when directed by a professional leader, have been shown to be effective in 
helping clients reduce substance abuse and improve overall outcomes of such treatment 
interventions.3  
It has been well established that a lack of dual diagnosis treatment interventions has been a 
major cause of potential substance related deaths.3–5 However, the ratio of mental health 
providers in correlation to drug overdose mortality rate has rarely been the focus in 
understanding the overarching issue of treating individuals with both a mental health disorder 
and substance use disorder. Mental health services in the United States are severely insufficient, 
with 56% of Americans seeking help.8 About 38% of Americans have had to wait longer than 
one week to receive a mental health treatment appointment, and nearly 46% have had to travel 
over an hour round trip for treatment.8 The mere lack of mental health providers may influence 
the rate of drug-related deaths, as individuals are simply unable to access the appropriate care. 
The purpose of this study is to examine the role that mental health provider ratio has in 
determining the drug overdose rate and mental distress rate specifically in Ohio during the year 
2020. This will be accomplished by using the population health data available on 
www.countyhealthrankings.org for each Ohio county. Comparisons will be made to the state of 
Michigan because of its proximal location and regional policy similarities,3 in order to determine 
whether potential correlations found in Ohio extend to other states in the Midwest.  
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Research Questions 
RQ1: How does the mental health provider ratio correlate with the drug overdose mortality rate 
in Ohio in 2020?  
RQ2: How does the mental health provider ratio correlate with the percent with frequent mental 
distress in Ohio in 2020?  
RQ3: What is the difference in the mental health provider ratio in Ohio in 2016 versus 2020?  
RQ4: What is the difference in the drug overdose mortality rate in Ohio in 2020 versus in 
Michigan in 2020?  
Methods 
Context/Protocol 
This study utilizes the variables of mental health provider ratio, percent with frequent mental 
distress, and drug overdose mortality rate. The variable of mental health providers is the ratio of 
population to mental health providers. The 2020 County Health Rankings used 2019 data for this 
measure. The NPI registry reveals a provider’s National Plan and Provider Enumeration System 
(NPPES) information. The variable of drug overdose deaths is the number of drug poisoning 
deaths per 100,000 population. The 2020 County Health Rankings used 2016-2018 data for this 
measure. Data on deaths were provided by the National Center for Health Statistics and from the 
National Vital Statistics System (NVSS). The data was submitted to the NVSS by vital 
registration systems operating in jurisdictions responsible for registering vital events, such as 
births, deaths, marriages, divorces, and fetal deaths. The variable of frequent mental distress is 
the percentage of adults reporting fourteen or more days of poor mental health per month. The 
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2020 County Health Rankings used 2018 data for this measure. The Behavioral Risk Factor 
Surveillance System (BRFSS) is a statewide random digital dial (RDD) telephone survey 
conducted annually in all states. Data from the BRFSS represents each state’s total non-
institutionalized population over eighteen years of age. The data is weighted using proportional 
fitting methods to reflect appropriate population distributions.  
Data Collection 
Access to mental health providers is important in access to care for individuals. Thirty 
percent of the population lives in a county that is denoted as a Mental Health Professional 
Shortage Area. The mental health aspects of the Affordable Care Act created increased coverage 
for mental health services, which would also contribute to increased shortages in the mental 
health provider workforce.9 The mental health provider ratio represents the number of 
individuals served by one mental health provider in a county if the population were equally 
distributed across providers. Counties with a population greater than one thousand people and 
zero mental health providers have a missing value and were thus excluded from the study. I will 
use the mental health provider ratio data set to correlate it with both drug overdose mortality rate 
and percent with frequent mental distress in Ohio in 2020. I will also use the mental health 
provider ratio to observe any changes in ratios in Ohio from 2016 to 2020.  
Drug overdose deaths are a largely preventable contributor to premature deaths. The United 
States is experiencing a drug overdose death epidemic, with the rate of deaths increasing by 
137% across the nation since 2000. There has been a 200% increase in deaths involving opioids, 
which include opioid pain relievers and heroin.9 Drug overdose deaths are the number of deaths 
from drug poisoning per 100,000 population. The deaths are counted in the county of residence 
of the deceased individual, not in the county where the individual died. Counties with less than 
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ten drug-poisoning deaths have a missing value and were thus excluded from this study. I will 
use the drug overdose mortality rate data to correlate it with the mental health provider ratio in 
Ohio in 2020. I will also use drug overdose data to compare rates between Ohio and Michigan in 
2020.  
Frequent mental distress is a similar measure to poor mental health days. It provides a 
slightly unique picture that places emphasis on those individuals who are experiencing more 
chronic and severe mental health issues.9 Individuals responded to the following question, “Now, 
thinking about your mental health, which includes stress, depression, and problems with 
emotions, for how many days during the past 30 days was your mental health not good?” 
Frequent mental distress is age-adjusted in order to account for the fact that poor health 
outcomes are more likely as age increases. Counties with missing data were excluded from the 
study. I will use the frequent mental distress data to correlate it with mental health provider ratio 
in Ohio in 2020.  
Data Analysis 
RQ1: How does the mental health provider ratio correlate with the drug overdose 
mortality rate in Ohio in 2020?  
To answer RQ1, I used a Pearson correlation test to compare the mental health provider 
ratio to the drug overdose mortality rate in Ohio during the year 2020. The data sets were derived 
from www.countyhealthrankings.org. The data includes values for both variables from each 
county in Ohio in 2020. I used SPSS to conduct the Pearson test for normally distributed data. 
The Pearson correlation will reveal a correlation coefficient. Generally, correlation strength is as 
follows: ≥ .7 is a strong correlation, ≥ .5 is moderate correlation, ≥ .3 is a weak correlation, and 
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below .3 is essentially no correlation. The significance (2-tailed) value gives the significance of 
the correlation. If Sig. is < 0.05, then the groups are statistically significantly different.  
RQ2: How does the mental health provider ratio correlate with the percent with frequent 
mental distress in Ohio in 2020?  
To answer RQ2, I used a Pearson correlation test to compare the mental health provider 
ratio to the percent with frequent mental distress in Ohio in 2020. The data sets were derived 
from www.countyhealthrankings.org. The data includes values for both variables from each 
county in Ohio in 2020. I used SPSS to conduct the Pearson test for normally distributed data. 
The Pearson correlation will reveal a correlation coefficient. Generally, correlation strength is as 
follows: ≥ .7 is a strong correlation, ≥ .5 is moderate correlation, ≥ .3 is a weak correlation, and 
below .3 is essentially no correlation. The significance (2-tailed) value gives the significance of 
the correlation. If Sig. is < 0.05, then the groups are statistically significantly different. 
RQ3: What is the difference in the mental health provider ratio in Ohio in 2016 versus 
2020?  
To answer RQ3, I used a paired samples t-test to compare the mental health provider ratio 
in Ohio in 2016 with the mental health provider ratio in Ohio in 2020. The data sets were derived 
from www.countyhealthrankings.org. The data includes values for the mental health provider 
ratio for each county in both 2016 and 2020. I used SPSS to conduct a paired samples t-test in 
order to compare the means of this data set in 2016 and 2020. If Sig is < 0.05, then the variables 
are statistically significantly different.  
RQ4: What is the difference in the drug overdose mortality rate in Ohio in 2020 versus in 
Michigan in 2020?  
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To answer RQ4, I used an unpaired samples t-test to compare the drug overdose mortality 
rate in Ohio in 2020 versus the drug overdose mortality rate in Michigan in 2020. The data sets 
were derived from www.countyhealthrankings.org. The data includes values for the drug 
overdose mortality rate for each county in both states in 2020. I used SPSS to conduct an 
unpaired samples t-test in order to compare the means of this data set in Ohio and Michigan in 
2020. If Sig is < 0.05, then the variables are statistically significantly different.  
Results 
RQ1: How does the mental health provider ratio correlate with the drug overdose 
mortality rate in Ohio in 2020?  
 In Ohio in 2020, we found a negative correlation (r = -0.305) between mental health 
provider ratio and drug overdose mortality rate (Figure 1). This negative correlation was 
statistically significant (p < 0.01). This reveals a moderate negative correlation between the two 
variables, suggesting that an increase in mental health provider ratio decreases the drug overdose 


























Mental Health Provider Ratio
Figure 1: Provider Rate and Drug Overdoses
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RQ2: How does the mental health provider ratio correlate with the percent with frequent 
mental distress in Ohio in 2020?  
 In Ohio in 2020, we found a negative correlation (r = -0.104) between mental health 
provider ratio and percent with frequent mental distress (Figure 2). However, the negative 
correlation was not statistically significant (p = 0.337). Despite the trend for an increase in 
mental health provider ratio to result in a decrease in the percent with frequent mental distress in 
Ohio during 2020, such a conclusion is not significantly supported by this data.  
RQ3: What is the difference in the mental health provider ratio in Ohio in 2016 versus 
2020?  
Comparing 2016 to 2020, we found that there was a significant difference in mental 
health provider ratio, with 2020 being lower than 2016 (t = 6.677, p < 0.001). The mean mental 
health provider ratio decreased from 1726.22 providers in 2016 to 944.00 providers in 2020 
(Table 1). These results suggest a decrease in the amount of mental health providers in Ohio over 



























Mental Health Provider Ratio
Figure 2: Provider Rate and Mental Distress
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Table 1 Descriptive Values for Ohio Mental Health Provider Ratio 
Ohio Mental Health 
Provider Ratio  
Mean N Std. Deviation 
2016 1726.22 88 1794.727 
2020 944.00* 88 936.668 
* statistically significantly different from 2016 (p < 0.001) 
RQ4: What is the difference in the drug overdose mortality rate in Ohio in 2020 versus in 
Michigan in 2020?  
Comparing Ohio to Michigan in 2020, we found that there was a significant difference in 
drug overdose mortality rate between the two Midwestern states (p < 0.001). Ohio’s 2020 drug 
overdose mortality rate mean of 32.219 deaths surpasses Michigan’s 2020 drug overdose 
mortality mean of 20.817 deaths (Table 2). These results suggest that the drug overdose mortality 
rate is different in these two states, despite their proximity. 
 
Table 2 Descriptive Values for Drug Overdose Mortality Rates  
Drug Overdose 
Mortality Rate  
Mean N Std. Deviation 
Ohio 33.219 84 13.585 
Michigan 20. 817* 63 8.804 
* statistically significantly different than Ohio (p < 0.001) 
Discussion 
Our results further verify the well-established importance of mental health providers in 
maintaining the well-being of individuals in numerous aspects. We chose to focus on the 
counties in Ohio during 2020, as we predicted the counties with fewer mental health providers 
would have a higher drug overdose mortality rate. The moderate negative correlation suggests 
counties with less mental health providers did in fact have a greater number of drug overdose 
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deaths. As previously mentioned, several studies indicate that individuals with the most severe 
psychiatric disorders also possess the highest rates of co-occurring substance use disorders.3–5 So 
it would follow that a deficit in the amount of available mental health providers would lead to a 
lack of mental health care, especially for those individuals with a dual diagnosis of substance use 
disorder.6 Ultimately, the inefficient treatment options would lead to a higher incidence of drug-
related deaths. The detrimental impact of minimal mental health care on drug overdose deaths is 
apparent, as Ohio previously reported a total of 3,764 residents dying from unintentional drug 
overdoses just in 2018.2 Additionally, this potential correlation led us to believe that we would 
see a similar effect of mental health providers on the percent of individuals with frequent mental 
distress. Although there was a weak negative correlation, it was statistically insignificant, 
suggesting that the category of mental distress is influenced by more factors than merely the 
availability of mental health providers.  
Due to the documented difficulty patients consistently endure to receive treatment by a 
mental health provider,8 we also predicted that Ohio’s mental health provider ratio decreased 
from 2016 to 2020. Our study revealed a statistically significant decrease in Ohio mental health 
providers over the span of these four years, aligning with prior studies discussing the great 
difficulties patients face in accessing mental health care. As individuals face longer wait times to 
be seen by a mental health professional and further travel distances even when they are able to 
access a provider,8 our study’s results support the concurrent decrease in mental health providers 
leading to such accessibility challenges. In addition to our questions regarding Ohio’s overall 
mental health accessibility, we chose to investigate Michigan, a surrounding Midwestern state, to 
observe any similarities between the two states in terms of drug overdose mortality rate. We 
found a statistically significant difference in the drug overdose mortality rate between Ohio and 
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Michigan, with Ohio possessing the higher number of drug-related deaths. We incorrectly 
predicted the two states would have a similar drug overdose mortality rate due to their regional 
similarities and potentially similar mental health resources. Perhaps the higher drug overdose 
mortality rate in Ohio is more representative of the fact that Ohio has faced a dire opioid crisis in 
preceding years far surpassing the drug use in Michigan.2 While our study establishes discrete 
relationships between mental health provider availability and drug overdose deaths, it would be 
beneficial to look deeper into the reasons for mental health provider shortages.  
Conclusion 
This study has further established the undoubted need for more mental health providers in 
Ohio to help combat the rise in drug overdose deaths due to co-occurring mental health disorders 
and substance use disorders. While our results support our predictions, we are aware of the 
limitations that arise from utilizing population health data from one publically available database 
County Health Rankings. In order to verify our results, future research would measure our 
findings in another population database assessing these same variables to ensure the validity of 
the reporting protocol. We realize that census data may not always be accurate, as many 
individuals may not respond to census reports while others may have multiple residences and 
report multiple times. Thus, the baseline sample size of each county may not be fully accurate, 
ultimately affecting the outcomes we discovered. If future research establishes differences in 
results with another population database, then it would be worthwhile to reassess the relationship 
between Ohio and Michigan’s drug overdose mortality rate as well, looking deeper into the 
reasons behind the difference in death rates.  
Moreover, there is a potential limitation in the reporting of percent with frequent mental 
distress, as individuals self-report their mental health. A standard measurement of mental health 
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was not used for these individuals, which may have contributed to our lack of significant results 
with this variable. In future studies, we hope to include a standard depression scale to record the 
number of poor mental health days reported by individuals. In this manner, we can ensure that 
each person has a similar baseline understanding of what features constitute a poor mental health 
day in medical terms. Despite these shortcomings, we are hopeful that these preliminary results 
will contribute to the wealth of existing knowledge regarding the importance of mental health in 
everyday life and help push for more comprehensive treatment of individuals with co-occurring 
mental health disorders and substance use disorders.  
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